New Study Reveals CSF Liquid Biopsy's Potential in Diagnosing Leptomeningeal Disease A recent study shows that CSF liquid biopsy could be a game changer in diagnosing leptomeningeal disease, addressing previous inconclusive findings.

New Study Reveals CSF Liquid Biopsy's Potential in Diagnosing Leptomeningeal Disease #USA #Chicago #Liquid_Biopsy #Belay_Diagnostics #Leptomeningeal_Disease

Belay Diagnostics Achieves 82% Clinical Impact Rate in CNS Lymphoma Testing with Summit™ and Vantage™ Belay Diagnostics' new study shows that their Summit and Vantage tests have significantly impacted CNS lymphoma cases, achieving an 82% rate of clinical effectiveness.

Belay Diagnostics Achieves 82% Clinical Impact Rate in CNS Lymphoma Testing with Summit™ and Vantage™ #USA #Chicago #Summit #Belay_Diagnostics #Vantage

Belay Diagnostics Unveils Breakthrough in CNS Cancer Genomic Profiling with Summit™ 2.0 Assay Belay Diagnostics has successfully validated its innovative Summit™ 2.0 assay for CNS cancers, providing crucial genomic insights from cerebrospinal fluid samples, enhancing patient care.

Belay Diagnostics Unveils Breakthrough in CNS Cancer Genomic Profiling with Summit™ 2.0 Assay #USA #Chicago #Belay_Diagnostics #CNS_Cancer #Summit_2.0

Belay Diagnostics Validates Vantage™ Assay for CNS Cancer Detection and Prognosis Belay Diagnostics has announced the successful validation of its Vantage™ assay for detecting MGMT promoter methylation in cerebrospinal fluid, significantly enhancing CNS cancer diagnosis.

Belay Diagnostics Validates Vantage™ Assay for CNS Cancer Detection and Prognosis #United_States #Chicago #Belay_Diagnostics #CNS_Cancer #Vantage_Assay

Belay Diagnostics Launches Innovative Summit™ Test for CNS Cancer Management in the US Belay Diagnostics introduces the Summit™ test for CNS cancer detection, enhancing personalized treatment through advanced liquid biopsy methods.

Belay Diagnostics Launches Innovative Summit™ Test for CNS Cancer Management in the US #USA #Chicago #Belay_Diagnostics #CNS_Cancer #Summit_Test